Boehringer Ingelheim Says It’s Agreed To Settle 2,935 Connecticut Pradaxa Suits

Mealey's (November 16, 2020, 11:47 AM EST) -- HARTFORD, Conn. — German drug maker Boehringer Ingelheim Pharmaceuticals Inc. on Nov. 6 told the Connecticut Supreme Court that it has reached a global settlement for all 2,935 U.S. lawsuits alleging injury from the company’s Pradaxa anticoagulant (Eugene Roberto v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. SC 20409, Charles F. Adkins v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No SC 20467, Conn. Sup.)....

Attached Documents

Related Sections